CCSD code G0260 – Endoscopically assisted oesophagectomy

Key Takeaways

CCSD code G0260 covers endoscopically assisted oesophagectomy only – open resection is coded separately

The operative note must explicitly state the endoscopic approach, instruments, and phase descriptions to support the claim

Most UK private insurers require pre-authorisation before G0260 is performed; missing this is the leading denial trigger

Oesophageal malignancy (ICD-10 C15.x) is the primary diagnosis pairing; Barrett’s with high-grade dysplasia (K22.x) is also accepted

Pabau’s billing workflows support CCSD-coded claims with structured documentation and insurer submission tracking

What is CCSD code G0260?

CCSD code G0260 is the Clinical Coding and Schedule Development (CCSD) procedure code for endoscopically assisted oesophagectomy, a minimally invasive surgical removal of all or part of the oesophagus.

The CCSD schedule is maintained by the Clinical Coding and Schedule Development Group and used by all major UK private medical insurers, including Bupa, AXA Health, Aviva, Vitality, and Cigna, as the standard framework for procedure billing. Surgeons billing privately in the UK submit G0260 against this schedule when the operative record confirms an endoscopic approach was used throughout, or used for the primary phase of the procedure.

G0260 sits within the CCSD’s oesophageal and gastric surgery chapter. It is distinct from open oesophagectomy codes in the same chapter. The code descriptor is specific to endoscopic assistance: a claim submitted under G0260 for a procedure performed entirely through open access will not survive audit or insurer review. According to the CCSD Technical Guide (October 2025), the code must reflect the surgical technique documented in the operative record, not the intended technique.

What the procedure involves: endoscopically assisted oesophagectomy

Endoscopically assisted oesophagectomy typically involves two coordinated phases performed under general anaesthesia, most commonly in the context of oesophageal cancer resection.

• Thoracoscopic phase: The chest is accessed using video-assisted thoracoscopic surgery (VATS). The thoracic oesophagus is mobilised from the mediastinum, and mediastinal lymphadenectomy is performed under direct camera vision.
• Laparoscopic abdominal phase: The stomach is mobilised laparoscopically. A gastric conduit (gastric tube or pull-up) is fashioned to serve as the oesophageal replacement.
• Reconstruction: The gastric conduit is pulled through the mediastinum and an anastomosis is created, either at the cervical level (McKeown/three-phase approach) or in the chest (Ivor Lewis/two-phase approach).
• Specimen handling: The resected oesophagus with lymph nodes is removed and sent for histopathological analysis. Accurate specimen description in the operative note supports both pathology coding and the G0260 claim.

The Ivor Lewis oesophagectomy (thoracoscopic chest phase and laparoscopic abdominal phase with intrathoracic anastomosis) and the McKeown oesophagectomy (adding a cervical anastomosis phase) are both eligible for G0260 when performed endoscopically. A transhiatal oesophagectomy performed without thoracoscopic access is not captured by G0260.

Clinical indications: when is G0260 appropriate?

G0260 is appropriate when oesophagectomy is clinically justified and performed endoscopically. Insurers assess medical necessity against published clinical guidelines, most notably NICE guideline NG83 on oesophago-gastric cancer, which recommends surgery for resectable oesophageal and junctional tumours in patients fit for major surgery.

• Oesophageal malignancy: Squamous cell carcinoma or adenocarcinoma staged as resectable (typically T1-T3, N0-N1, M0 following staging CT and PET-CT). This is the primary indication driving the majority of G0260 claims.
• Barrett’s oesophagus with high-grade dysplasia: When endoscopic mucosal resection or ablation has failed or is not appropriate, surgical resection may be indicated.
• Benign oesophageal stricture: Unresponsive to repeated dilatation, particularly when associated with significant dysphagia or aspiration risk.
• Achalasia (end-stage): Rare indication where oesophageal function is irretrievably lost and resection is preferred over myotomy.

Each insurer may apply its own criteria overlay. Staging information, MDT minutes, and the referring oncologist’s letter should accompany the pre-authorisation request.

G0260 vs related CCSD codes: choosing the right code

The most consequential coding decision for oesophagectomy is approach: open versus endoscopic. Selecting the wrong code is both a claim integrity issue and a potential audit trigger. The table below compares G0260 against the most commonly confused adjacent codes.

Approach variants and their impact on code selection

Both the Ivor Lewis (two-phase, intrathoracic anastomosis) and McKeown (three-phase, cervical anastomosis) oesophagectomies are eligible for G0260 when performed thoracoscopically and laparoscopically. The anastomosis level does not determine code eligibility; the access method does.

Robotic oesophagectomy represents an evolving area. Some insurers accept G0260 for robot-assisted cases on the basis that the robotic system is an endoscopic instrument platform. Others require a separate robotic supplement code or apply a different fee schedule.

Coders should confirm the individual insurer’s position before claiming G0260 for a robotic case. When the procedure converts from endoscopic to open intraoperatively, the operative note must document the conversion, and the claim should reflect the open code rather than G0260.

ICD-10 diagnosis codes that pair with G0260

Every G0260 claim requires an ICD-10 diagnosis code to establish the clinical reason for the procedure. The primary pairing codes are drawn from the C15 oesophageal malignancy chapter. Verify codes against the current CCSD and insurer guidance for the submission year, as accepted pairings are reviewed annually.

Use the most specific code available. C15.9 should not be used when the operative report and staging document identify the tumour location. The NHS Classifications Browser provides current UK ICD-10 fifth edition code definitions for reference.

G0260 documentation requirements for a valid claim

The operative note is the single most important document for a G0260 claim. Vague or incomplete documentation is the leading cause of denial and audit failure. The GMC’s professional standards require that operation notes are completed immediately after surgery; delay or retrospective amendment undermines claim credibility. Using clinical compliance software with structured operative templates can reduce documentation gaps before the invoice is submitted.

The operative note must explicitly address each of the following to support G0260:

• Explicit statement of endoscopic approach: Name the technique used: thoracoscopic, video-assisted thoracoscopic (VATS), laparoscopic, or robot-assisted. “MIS oesophagectomy” without elaboration is not sufficient for all insurers.
• Instruments and ports: Number and placement of thoracoscopic ports, laparoscopic trocar positions, and any additional instruments used (harmonic scalpel, staplers, clip appliers).
• Phase descriptions: Each operative phase documented in sequence: thoracoscopic mobilisation, laparoscopic gastric preparation, conduit formation, conduit pull-through, anastomotic technique (hand-sewn or stapled), and anastomosis level.
• Mediastinal dissection detail: Lymph node stations dissected, completeness of two-field or three-field lymphadenectomy, and any intraoperative findings affecting the dissection.
• Anastomosis confirmation: Type of anastomosis (circular stapler, linear stapler, hand-sewn), leak test performed, and result.
• Specimen description: Oesophagus length, attached stomach cuff, proximal and distal margins noted, lymph nodes included in specimen.
• Conversion note: If conversion to open occurred, this must be explicitly documented with the reason. The code should then be changed to the appropriate open procedure code before submission.

Prior authorisation and medical necessity for G0260

All major UK private medical insurers require pre-authorisation before oesophagectomy is performed. Submitting a G0260 claim without a valid authorisation reference number is the single most common reason for initial denial. Each insurer maintains its own authorisation portal and criteria, but the following applies across Bupa, AXA Health, Aviva, and Vitality Health as standard practice.

• Referral documentation: A letter from an oncologist, gastroenterologist, or specialist referring clinician confirming the diagnosis, staging, and MDT recommendation for surgery.
• Staging evidence: CT chest/abdomen/pelvis report, PET-CT report where performed, and endoscopy/biopsy histology confirming malignancy or high-grade dysplasia.
• MDT record: Minutes or outcome letter from the relevant upper GI cancer MDT meeting recommending surgical resection.
• Surgeon’s letter: Consultant’s letter confirming the proposed approach (endoscopic), the clinical indication, and the intended date of surgery.
• Pre-operative fitness assessment: Relevant cardiorespiratory investigations and anaesthetic assessment if requested by the insurer.

The Bupa CCSD codes guide covers the specific submission and authorisation requirements for Bupa-insured patients in more detail. For other insurers, check the relevant portal directly: Bupa code search and Aviva’s fee schedule and guidelines both provide procedure-specific criteria.

Manage CCSD billing from one place

Pabau supports structured operative documentation, CCSD-coded invoicing, and insurer submission tracking so your surgical billing admin doesn’t fall through the gaps.

Book a demo

Anaesthesia, assistant surgeon, and add-on code considerations

Oesophagectomy is a major surgical procedure requiring general anaesthesia and, in most cases, a surgical assistant. The billing rules for these supplementary services vary by insurer. The table below summarises what can typically be claimed alongside G0260 and what is considered bundled.

For surgical billing admin spanning multiple contributors to a complex procedure like G0260, a coordinated invoicing approach between the surgical team, anaesthetist, and hospital reduces the risk of duplicate or conflicting claims.

Common claim denial reasons for G0260 and how to avoid them

G0260 claim denials follow a predictable pattern. Most are preventable with pre-submission checks. Effective claims management software can flag missing authorisation references and documentation gaps before the invoice reaches the insurer.

• Missing or expired pre-authorisation: The most common denial trigger. The authorisation reference number must appear on the claim, and the claim must be submitted within the validity window granted. Emergency extensions require separate insurer notification.
• Operative note fails to confirm endoscopic approach: A note that describes the outcome without specifying the access method leaves the insurer no basis to distinguish G0260 from an open code. Explicit instrument naming and port placement are required.
• Wrong diagnosis code pairing: Submitting C15.9 (unspecified oesophageal malignancy) when a specific subsite code (C15.1 or C15.2) is available can trigger a medical necessity query. Similarly, using only K22.70 (Barrett’s without dysplasia) as the primary code is insufficient to justify oesophagectomy.
• Unbundling of bundled services: Claiming intraoperative endoscopy as a separate line item alongside G0260 is a common unbundling error. Check the specific insurer’s schedule for bundling rules before itemising add-on services.
• Conversion to open not reflected: If the endoscopic approach was converted to open intraoperatively and the claim still shows G0260, the insurer may deny on grounds of code mismatch. The operative note and claim code must align.
• Assistant surgeon not separately recognised: Some insurers require the first assistant to hold individual recognition with them before a separate assistant-surgeon claim can be processed. Verify recognition status in advance.

Modifier usage with CCSD code G0260

CCSD modifiers supplement the base code to communicate additional clinical or administrative information to the insurer. The modifiers most relevant to G0260 are as follows:

Modifier rules vary between insurers. The CCSD schedule provides the base framework; individual insurer bulletins (available via Bupa, AXA, Aviva, and Vitality provider portals) specify how each modifier is applied and priced.

Reimbursement and fee benchmarks for G0260 in UK private practice

Oesophagectomy is one of the highest-banded surgical procedures in the CCSD schedule, reflecting its clinical complexity and operative duration. Actual reimbursement for G0260 depends on the individual insurer’s fee schedule, whether the surgeon holds a recognised consultant contract with that insurer, and any negotiated rate variation agreed at the hospital or individual level.

Fee ranges in UK private practice are not publicly standardised, but consultants can benchmark against several sources. The Healix fee schedule publishes CCSD-based rates and is openly accessible. The Aviva fee schedule is available to recognised Aviva providers and covers the full CCSD surgical chapter. Cigna UK’s schedule is accessible via the Cigna provider portal for recognised consultants.

Key factors affecting G0260 reimbursement in practice:

• Insurer recognition: Consultants without recognition with a specific insurer are typically limited to the insurer’s standard published rate, with any excess billed to the patient.
• Hospital contract: Whether the independent hospital (Spire, Nuffield, BMI) has a block contract or a cost-per-case agreement with the insurer affects the facility component of the total invoice.
• Complexity uplifts: Some insurers apply complexity indicators for procedures involving oncological resection or technical difficulty; this must be justified in the pre-authorisation documentation.
• Annual schedule updates: CCSD fee schedules are reviewed periodically. Ensure the fee cited on the invoice matches the schedule in force at the date of procedure, not a prior year’s figure.

Surgeons new to private practice management should obtain recognised status with each insurer before performing insured procedures, as unrecognised consultant claims are frequently reduced or redirected to the patient. The process of gaining recognition typically requires CV submission, a certificate of good standing, and evidence of surgical activity in the relevant subspecialty. More context on the benefits of running a private surgical practice alongside NHS commitments is covered in detail separately.

Conclusion

CCSD code G0260 is a high-value, approach-specific code where the difference between a clean claim and a denial often comes down to a single sentence in the operative note. Documenting the endoscopic technique explicitly, securing pre-authorisation before the list date, and pairing the claim with the most specific available ICD-10 diagnosis code are the three actions that most reliably prevent denial.

Pabau supports structured surgical documentation and CCSD-coded invoicing workflows, helping thoracic surgery teams keep billing records aligned with operative documentation from the outset.

To see how Pabau handles private billing workflows for complex surgical procedures, book a demo.

Continue your research

Need a full guide to Bupa CCSD coding and submission? Bupa CCSD codes guide covers the full submission process, recognised procedure chapters, and Bupa-specific billing rules for private consultants.

Looking to streamline private practice administration? Billing privately as an NHS consultant explains how to structure your private practice, insurer recognition, and invoicing workflows when moving into independent practice.

Want to reduce documentation-related claim failures? Compliance management software helps surgical teams maintain structured operative templates and audit-ready records for CCSD billing.

Frequently asked questions